SCHEMBL23274221

SCHEMBL23274221

C#CCNC(=O)COCC(=O)Nc1ccc(CCC(=O)N2CCC2=O)cc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 1/20 0.43
ALDH1A1 P00352 3/20 0.41
HPGD P15428 1/20 0.41
NAMPT P43490 2/20 0.37
MAPT P10636 6/20 0.37
NPC1 O15118 2/20 0.36
SMN1; SMN2 Q16637 2/20 0.36
MAPK1 P28482 1/20 0.36
RAB9A P51151 1/20 0.36
LMNA P02545 2/20 0.36
ABCB1 P08183 1/20 0.35
HDAC3 O15379 1/20 0.35
HDAC4 P56524 1/20 0.35
HDAC1 Q13547 1/20 0.35
HDAC7 Q8WUI4 1/20 0.35
HDAC2 Q92769 1/20 0.35
HDAC10 Q969S8 1/20 0.35
HDAC11 Q96DB2 1/20 0.35
HDAC8 Q9BY41 1/20 0.35
HDAC6 Q9UBN7 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14297017 0.89 POLB (0.48) POLBALDH1A1HPGDNAMPTMAPT
SCHEMBL14297024 0.87 POLB (0.47) POLBALDH1A1HPGDNAMPTMAPT
SCHEMBL13643864 0.86 POLB (0.47) POLBALDH1A1HPGDNAMPTMAPT
SCHEMBL13625396 0.86 POLB (0.47) POLBALDH1A1HPGDNAMPTMAPT
SCHEMBL4400681 0.85 POLB (0.46) POLBALDH1A1HPGDNAMPTMAPT
SCHEMBL14297023 0.85 ALDH1A1 (0.57) POLBALDH1A1HPGDNAMPTMAPT
SCHEMBL16425205 0.85 HPGD (0.50) POLBALDH1A1HPGDNAMPTNPC1
SCHEMBL14203798 0.84 HPGD (0.49) POLBALDH1A1HPGDNAMPTRAB9A
SCHEMBL16404365 0.84 POLB (0.45) POLBALDH1A1HPGDMAPTNPC1
SCHEMBL13625469 0.84 POLB (0.45) POLBALDH1A1HPGDMAPTNPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230012213-A1 NOVEL CONJUGATION CHEMISTRY FOR CATALYTIC ANTIBODY 38C2 THE SCRIPPS RESEARCH INSTITUTE 2023-01-12 US disclosed
EP-4048311-A1 NOVEL CONJUGATION CHEMISTRY FOR CATALYTIC ANTIBODY 38C2 University of Florida Research Foundation, Incorporated (US) 2022-08-31 EP disclosed
CN-114846030-A Novel conjugation chemistry that catalyzes antibody 38C2 佛罗里达大学研究基金会公司 2022-08-02 CN disclosed
WO-2021080846-A1 NOVEL CONJUGATION CHEMISTRY FOR CATALYTIC ANTTIBODY 38C2 THE SCRIPPS RESEARCH INSTITUTE (US) 2021-04-29 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230012213-A1 NOVEL CONJUGATION CHEMISTRY FOR CATALYTIC ANTIBODY 38C2 PTMS, MRPS34, SDC2 POLB 1622/4885ALDH1A1 1323/4885HPGD 4842/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.